Navigation Links
Pharmos Corporation Reports 2008 Third Quarter Results
Date:11/6/2008

result from non recurring 2007 costs related to contractual payment obligations associated with the retirement of the Company's chief executive officer, higher legal and accounting fees in 2007, a one time IRS section 382 tax analysis cost incurred in 2007, a non recurring recruitment fee of $42,000 in 2007 and higher BOD meeting costs in 2007.

The company believes that the current cash and cash equivalents totaling $6.1 million as of September 30, 2008 will be sufficient to support the currently planned continuing operations through at least December 31, 2008. The company is actively pursuing efforts to raise additional capital but there can be no assurance that such efforts will be successful.

About Pharmos Corporation

Pharmos discovers and develops novel therapeutics to treat a range of indications including specific diseases of the nervous system such as disorders of the brain-gut axis (GI/IBS), pain/inflammation, and autoimmune disorders. The Company's lead product in development, dextofisopam, is undergoing Phase 2b testing in IBS patients. Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033). The Company also has a proprietary technology platform focusing on discovery and development of synthetic cannabinoid compounds with a focus on CB2 receptor selective agonists. Various CB2-selective compounds from Pharmos' pipeline have completed preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and other disorders. Pharmos is also working to commercialize its proprietary NanoEmulsion drug delivery system, which is in clinical-stage development for topical application of analgesic and anti-inflammatory agents.

Safe Harbor Statement

Statements made in this press release related to the business outlook and future financial performance of Phar
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pharmos Restructures Operations in Israel
2. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Brooke Franchise Corporation Announces Selected July Results
5. MedThink Communications Retained by NanoBio Corporation
6. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and ... mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, to ...
(Date:7/7/2015)... ... July 07, 2015 , ... A ... facial rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by ... more youthful than she has in some time and speculate that she might ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters to ... is a state of the art building, located with easy access to New York ... said, "We are pleased to service our clients from such a premier location and ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Safe Catch is ... single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market ... , “We developed the technology to test every fish for mercury,” said Safe Catch ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of teenagers or young ... an open-ended holistic treatment center for drug and alcohol abuse located in Southwest Michigan. ... Research has shown a significant increase in the “club drug” use among high school ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2
... Britons are packed with dust mites, fungus and skin scales.// ... to contain up to 20,000 live house dust mites in addition ... unwashed duvet revealed over an ounce and a half of debris ... addition it was found that more than four in ten people ...
... in Melbourne Australia have performed the first incompatible blood ... Royal Melbourne hospital have performed a kidney transplant despite ... was explained that Davorin Gelemanovic, 24, who is of ... from his father, who has type A blood. Mr ...
... Tata group, the Essar group and the Jindal group ... that would ensure medicare for people leaving Below Poverty ... first public-private partnership, the Sarva Swasthya Mission trust is ... major corporate groups, an official release said here today ...
... well as a good balanced diet can avert strokes in ... 1993 with over 37,600 women as participants//. ,All ... rated on a "health index score." The scores ranged from ... the woman. ,The women were followed for a ...
... of India have accorded sanction to the Karnataka government to ... from this academic year, the state assembly was informed today. ... in Belgaum and Mandya, Medical Education Minister V S Acharya ... MCI has approved an intake of 100 students in each ...
... The death toll in Dooars and Terai region of North ... and a half months till yesterday. // ,Chief ... malaria deaths were reported in Dooars region of Jalpaiguri district, ... days in the area., ,In the Terai region at ...
Cached Medicine News:Health News:Dust mites use Duvets as their Haven 2
(Date:7/7/2015)... , July 7, 2015  Dedicated to promoting ... Leonard,s® Healthcare Corp. took the purple pledge in ... is Alzheimer,s & Brain-Awareness Month, a time to shine ... the world and all the people in our community ... those struggling with the disease, and helps mobilize friends, ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 /PRNewswire/ ... provider of innovative clinical trial data management solutions, has ... Reports) recent publication named " EDC and eCOA / ... ISR Reports is one of the leading providers of ... report evaluated 22 EDC and eCOA / ePRO tools ...
(Date:7/7/2015)... July 7, 2015   Bionik Laboratories Corp. ... company with a core focus in robotic exoskeleton ... the "Company"), announced today that it has completed ... units consisting of its common stock and warrants ... in a private placement transaction.  This equity financing ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... , , , ROCKVILLE, Md., ... of getting breast cancer, but each drug carries distinct potential harms ... for Healthcare Research and Quality. , , Drugs ... women with a family history of breast cancer or other risk ...
... , HONG KONG, Sept. 15 ... pro-healing stent, OrbusNeich,s Genous Bio-engineered R stent, and preclinical data ... week at the Transcatheter Cardiovascular Therapeutics symposium, TCT 2009, in ... M.D., Ph.D., of the Academic Medical Center in Amsterdam will ...
Cached Medicine Technology:Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says 2Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says 3Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 3
... Re-insulation capabilities that extend the life of ... bring them back to life, expertise you ... trademark. Our maintenance capabilities always help you ... Economical and fast, not only do we ...
... know their instruments will consistently perform correctly. ... Instrument for instrument repair than any other ... carbide inserts and all repairs are micro-inspected ... enjoy 24-hour turnaround from our repair center ...
... fiber and video scopes including bronchoscopes, cystoscopes, ... OR and endoscopy. Quality is of utmost ... the standards of the OEM. We back ... defects in materials and workmanship. Quotes are ...
Inquire...
Medicine Products: